Bellevue Group AG Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001674546

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2023 · 161 positions · Total reported value $6.54B · Top-10 concentration 39.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 61.0% · 17 new · 64 cut · 24 exited

Active Share (vs S&P 500): 94.1% · vs QQQ: 96.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +12.4% · vs SPY -2.4% · Prev Value $4.20B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2023 13F filing, Bellevue Group AG disclosed 161 equity positions with a combined reported value of $6.54B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 39.8% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were IONS ($440.84M), ARGX ($330.68M), NBIX ($320.24M). By sector, the heaviest allocations are Health Care 83.5%, Industrials 2.6%. Versus the prior quarter, allocation shifted toward Health Care (+1.2pp).

Versus the prior quarter, Bellevue Group AG opened 17 new positions, trimmed 64 and fully exited 24, a turnover rate of 61.0% of positions. The portfolio's overlap with the prior quarter was 76% of names.

The largest new positions opened in Q4 2023 were BHVN ($46.01M), ZLAB ($3.71M), SIBN ($2.63M).

Of the 24 positions fully exited versus the prior quarter, the largest were JAZZ ($34.46M), PNT ($15.68M), AMED ($9.94M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • BHVN BIOHAVEN LTD · $46.01M
  • ZLAB Zai Lab Ltd · $3.71M
  • SIBN SI BONE INC COM · $2.63M
  • EHC ENCOMPASS HEALTH CORP · $793.97K
  • RCKT ROCKET PHARMACEUTICALS INC · $629.37K
  • VERV VERVE THERAPEUTICS INC · $543.66K
  • DVA DAVITA INC · $398.09K
  • LULU LULULEMON ATHLETICA INC · $393.69K

Fully Exited (vs previous quarter)

  • JAZZ JAZZ PHARMACEUTICALS PLC · prev qtr: $34.46M
  • PNT POINT BIOPHARMA GLOBAL INC · prev qtr: $15.68M
  • AMED AMEDISYS INC · prev qtr: $9.94M
  • MRSN MERSANA THERAPEUTICS INC · prev qtr: $6.63M
  • SGEN SEAGEN INC · prev qtr: $4.67M
  • OLK OLINK HLDG AB · prev qtr: $3.20M
  • GH GUARDANT HEALTH INC · prev qtr: $2.21M
  • AKRO AKERO THERAPEUTICS INC · prev qtr: $1.26M

Insider Transactions (Form 4)

Latest Bellevue Group AG buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Bellevue Group AG files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 148 positions worth $4.75B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 148 positions · $4.75B reported value (Q2 2026)
  • Top 10 holdings = 42.9% of reported value
  • Largest position: AMGN (AMGEN INC) at 6.5%
  • Average position size: $32.11M

Sector Tilt

  • Health Care 92.6%
  • Industrials 1.7%
  • Information Technology 0.4%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q2 2026: 17 new, 39 added, 64 reduced, 24 exited
  • 28 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 83.5%
Technology 0.9%
Energy 0.0%
Other 11.6%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 8.71M $440.84M 6.74%
6.74%
Reduce
2 869.21K $330.68M 5.06%
5.06%
Reduce
3 2.43M $320.24M 4.90%
4.90%
Reduce
4 736.39K $299.63M 4.58%
4.58%
Reduce
5 832.04K $280.70M 4.29%
4.29%
Hold
6 3.07M $219.62M 3.36%
3.36%
Reduce
7 1.91M $189.79M 2.90%
2.90%
Add
8 3.17M $183.29M 2.80%
2.80%
Add
9 885.32K $169.46M 2.59%
2.59%
Reduce
10 1.54M $169.03M 2.59%
2.59%
Reduce
11 5.09M $146.01M 2.23%
2.23%
Add
12 465.72K $139.47M 2.13%
2.13%
Reduce
13 2.16M $135.42M 2.07%
2.07%
Reduce
14 1.83M $114.08M 1.75%
1.75%
Reduce
15 914.59K $113.49M 1.74%
1.74%
Add
16 2.51M $103.22M 1.58%
1.58%
Add
17 2.42M $95.83M 1.47%
1.47%
Add
18 9.95M $95.75M 1.47%
1.47%
Add
19 388.07K $94.62M 1.45%
1.45%
Add
20 4.01M $89.32M 1.37%
1.37%
Hold
21 970.77K $79.97M 1.22%
1.22%
Add
22 2.38M $78.51M 1.20%
1.20%
Reduce
23 1.02M $77.70M 1.19%
1.19%
Reduce
24 1.05M $77.52M 1.19%
1.19%
Reduce
25 3.51M $76.13M 1.17%
1.17%
Hold
26 138.15K $72.73M 1.11%
1.11%
Reduce
27 7.32M $71.78M 1.10%
1.10%
Add
28 2.29M $71.00M 1.09%
1.09%
Reduce
29 976.05K $66.68M 1.02%
1.02%
Add
30 5.94M $65.36M 1.00%
1.00%
Add
31 1.94M $65.32M 1.00%
1.00%
Reduce
32 289.90K $62.90M 0.96%
0.96%
Add
33 1.99M $58.93M 0.90%
0.90%
Reduce
34 900.40K $56.37M 0.86%
0.86%
Hold
35 4.51M $54.13M 0.83%
0.83%
Hold
36 94.11K $52.24M 0.80%
0.80%
Reduce
37 7.90M $52.13M 0.80%
0.80%
Hold
38 217.76K $51.48M 0.79%
0.79%
Reduce
39 203.05K $51.07M 0.78%
0.78%
Reduce
40 107.79K $50.83M 0.78%
0.78%
Reduce
41 2.11M $50.57M 0.77%
0.77%
Reduce
42 635.37K $50.57M 0.77%
0.77%
Add
43 821.80K $49.19M 0.75%
0.75%
Add
44 3.95M $47.46M 0.73%
0.73%
Hold
45 1.07M $46.01M 0.70%
0.70%
New
46 100.47K $46.00M 0.70%
0.70%
Reduce
47 141.15K $45.57M 0.70%
0.70%
Add
48 215.60K $43.86M 0.67%
0.67%
Add
49 159.41K $43.68M 0.67%
0.67%
Reduce
50 535.18K $41.38M 0.63%
0.63%
Add

FAQ

What did Bellevue Group AG buy in 2023-Q4?

In its 2023-Q4 13F filing, Bellevue Group AG reported 161 equity positions worth $6.54B in aggregate; its largest disclosed positions were IONS ($440.84M), ARGX ($330.68M), NBIX ($320.24M).

How large is Bellevue Group AG's portfolio?

Bellevue Group AG reported $6.54B of long equity holdings across 161 positions as of 2023-Q4. Top-10 holdings account for 39.8% of reported value.

What is Bellevue Group AG's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bellevue-group-ag/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →